Jyong Biotech Ltd. (MENS)
NASDAQ: MENS · Real-Time Price · USD
2.150
+0.010 (0.47%)
At close: Sep 24, 2026, 4:00 PM EDT
2.290
+0.140 (6.51%)
After-hours: Sep 24, 2026, 6:06 PM EDT
Jyong Biotech Employees
Jyong Biotech had 27 employees as of December 31, 2025. The number of employees decreased by 4 or -12.90% compared to the previous year.
Employees
27
Change
-4
Growth
-12.90%
Revenue / Employee
n/a
Profits / Employee
-$173,000
Market Cap
159.60M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 27 | - | - |
| Jun 30, 2024 | 31 | - | - |
| Dec 31, 2023 | 31 | -1 | -3.13% |
| Dec 31, 2022 | 32 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Innate Pharma | 164 |
| Tonix Pharmaceuticals Holding | 142 |
| Voyager Therapeutics | 141 |
| MediWound | 121 |
| Acumen Pharmaceuticals | 61 |
| NovaBridge Biosciences | 30 |
| AN2 Therapeutics | 21 |
MENS News
- 17 days ago - Jyong Biotech Transcript: AGM 2026 - Transcripts
- 21 days ago - Jyong Biotech Announces Participation in StockFan Virtual Investor Non-Deal Roadshow - GlobeNewsWire
- 2 months ago - Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships - GlobeNewsWire
- 2 months ago - Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention - GlobeNewsWire
- 3 months ago - Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview - GlobeNewsWire
- 4 months ago - Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025 - GlobeNewsWire
- 4 months ago - Jyong Biotech Annual report: Q4 2025 - Filings
- 4 months ago - Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple Competitive Advantages for New Drug Portfolio - GlobeNewsWire